SynthesisOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2025
Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta-Analysis.
Synthesis in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta-Analysis.Diabetes/metabolism research and reviews · 2026Pooled it
- Dementia in type 2 diabetes: risk factors, disease processes and opportunities for prevention across the lifespan.Diabetologia · 2026Review
- Diabetes Mellitus as a Risk Factor in Recurrent Vestibular Disorders: An Update.Audiology research · 2026Review
- Hearing impairment and ocular complications in Zucker diabetic fatty rats: a cross-sectional study across disease progression.Scientific reports · 2026Article
- Development and Validation of an Interpretable Machine Learning Model Based on Routine Blood Biomarkers: For Predicting Age-Related Hearing Loss.Diagnostics (Basel, Switzerland) · 2026Article
- Cochlear Homeostasis in Sensorineural Hearing Loss: Mechanisms, Implications, and Therapeutic Prospects.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo conduct a systematic review and meta-analysis to assess the association between type 2 diabetes and hearing loss. DATA SOURCES: Search conducted in PubMed and Scopus databases for articles published between January 2019 and April 2024. REVIEW
methodsQuality assessment and risk of bias analysis were conducted using the Newcastle-Ottawa scale, and meta-analyses of pooled data were performed with Cochrane's Review Manager.
resultsFrom 8354 initially identified articles, 17 met the inclusion criteria. The prevalence of hearing loss in patients with type 2 diabetes range from 40.6% to 71.9%, which was significantly higher than in controls (odds ratio [OR]: 4.19; 95% confidence interval [CI]: 1.22-14.37). The mean pure-tone audiometric thresholds of the diabetic group were 3.19 dB higher (95% CI: 1.08-5.19) and were higher for both low frequencies (1.11 dB, 95% CI: 0.62-1.57) and, more severely, for high frequencies (2.3 dB, 95% CI: 1.97-2.63). Patients with moderate (0.57%, 95% CI: 0.1-1.05) and severe-to-profound (0.95%, 95% CI: 0.02-1.87) hearing loss had higher mean HbA1c levels than controls. The prevalence of hearing loss was significantly higher among patients with a diagnosis of diabetes for more than 10 years (OR 2.07, 95% CI: 1.45-2.94). The gender of diabetic patients was found to have no influence.
conclusionThe prevalence of hearing loss among individuals with type 2 diabetes ranges from 40.6% to 71.9%. Compared to the control group, the risk of hearing loss is 4.19 times higher and is predominantly observed at higher frequencies. The duration of diabetes and HbA1c levels are significant factors in the prevalence of hearing loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.